DoW Parkinson's, Investigator-Initiated Research Award
This grant funds rigorous, multidisciplinary Parkinson’s disease research addressing FY26 focus areas, allows multiple PIs, requires preliminary data, and supports clinical trials.
Funder: Defense Health Agency Contracting Activity - DHACA
Due Dates: October 23, 2026: Pre-Application (Letter of Intent) | November 6, 2026: Full Application | November 13, 2026: End of Application Verification Period
Funding Amounts: ~$10M total; up to $2M total costs per award over 3 years; ~5 awards expected
Summary: Supports rigorous, multidisciplinary, high-impact research projects addressing key focus areas in Parkinson’s disease, including clinical trials.
Key Information: Preliminary data are required; Partnering PI option available; clinical trials allowed.
Description
This opportunity funds investigator-initiated research projects that address critical gaps in Parkinson’s disease (PD) research. Supported by the Department of Defense’s Congressionally Directed Medical Research Programs (CDMRP), the award is designed for highly rigorous, multidisciplinary, and high-impact research with the potential to advance scientific understanding or treatment of PD. Projects must address at least one of the specified FY26 PRP Focus Areas, which include disease heterogeneity, novel model systems, mechanisms/biomarkers of unmet medical needs, and interventions for PD.
Distinctive features include:
- Partnering Principal Investigator (PI) Option: Allows for multi-PI teams, with clear delineation of roles.
- Preliminary Data Requirement: Applications must include supporting preliminary data.
- Clinical Trials: Both clinical and preclinical research are eligible, including clinical trials.
The program seeks research that is relevant to the health care needs of Service Members, Veterans, their families, and the general public.
